Skip to content

A clinical trial of the safety and efficacy of laser acupuncture and electroacupuncture on knee osteoarthritis patients

A randomized, controlled, assessor blinded, investigator initiated clinical trial testing the safety and efficacy of laser acupuncture and electroacupuncture on knee osteoarthritis patients

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CRIS
Registry ID
KCT0008938
Enrollment
45
Registered
2023-11-10
Start date
2023-11-30
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : This study is an exploratory clinical trial led by researchers, aiming to assess the safety and efficacy of medical laser probes and electrical acupuncture for patients with degenerat

Sponsors

Dongshin University Mokpo Oriental Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) men and women over the age of 50 2) A person who falls under the ACR criteria 'clinical and radiological findings (II)', has pain in the knee joint, and is accompanied by crude stiffness and creptus + osteophytes that last less than 30 minutes 3) Knee osteoarthritis of Grade 2 or higher according to the Kellgren-Lawrence grading scale (K-L grade) according to x-ray examination 4) Of the bilateral knee joints, A person who has pain in the knee joint at least one joint 5) A person whose pain scale (VAS) of 40 mm or more has lasted for more than 6 months during activity and rest 6) A person who voluntarily submitted a written consent form and signed the consent form for participation in clinical trials without any problems in reading and writing Korean 7) A person with a prevalence period of degenerative knee osteoarthritis for more than 3 months

Exclusion criteria

Exclusion criteria: 1) a person unable to walk due to knee pain 2) In the case of knee surgery accompanied by loss of connective tissue around the knee 3) Patients with rheumatoid arthritis or other metabolic arthritis 4) A person who has received injections such as steroids or prologue therapy around the joint cavity or knee within 3 months of screening, or who is taking drugs for the purpose of treating osteoarthritis 5) Those who need attention to invasive laser needle procedures or sedimentation stimulation (those with hemicoagulant disorders, severe skin diseases at the treatment site, those with a metallic device in the knee area, and those with implantable devices such as a pacemaker) 6) Subjects who are vulnerable by definition by the clinical trial review committee of the medical institution where the clinical trial is conducted 7)You're pregnant, or you're pregnant The one who prepares 8) A person who determines that the tester is unfit to participate in clinical trials due to other reasons 9) who are participating in another clinical trials 10) A person who receives medical treatment as part of social insurance, compensation and compensation

Design outcomes

Primary

MeasureTime frame
Variation of 100mm pain scale (VAS) at 5 weeks compared to Baseline;Adverse event;Skin condition and vital signs;Blood test

Secondary

MeasureTime frame
Variation of 100mm pain scale (VAS) at 1-5 weeks relative to Baseline;Changes in the knee knee osteoarthritis symptom assessment (KOOS) score at 1-5 weeks compared to Baseline;Change in Quality of Life Assessment (EQ-5D-5L) score at 1-5 weeks compared to Baseline;Changes in general health (PGA) scores from 1 to 5 weeks compared to Baseline

Countries

Korea, Republic of

Contacts

Public Contactsunjong kim

Dongshin University Mokpo Oriental Hospital

mofoster@daum.net+82-61-280-7700

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026